Pharma regulator digitizes drug approval process

Pharma regulator digitizes drug approval process. The drug regulator has overhauled its approval framework by integrating digital systems and advanced technology to streamline processes. This move aims to cut approval time by 30–40% and improve transparency across drug evaluations. The reform is expected to benefit domestic and export-oriented pharma firms in the medium term.
📊 STOCKS: | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Pharma